Latest News
ABEC opens new manufacturing facility in Wilson, NC
11 September 2026 - ABEC, a provider of customised solutions and services for biopharmaceutical manufacturing, on Thursday announced the grand opening of its newest manufacturing facility in Wilson, North Carolina.An official ribbon-cutting ceremony ...
AbbVie declares quarterly dividend of USD1.73 per share
11 September 2026 - US pharmaceutical company AbbVie (NYSE:ABBV) announced on Thursday that its board of directors has declared a quarterly cash dividend of USD1.73 per share.This amount is unchanged from the previous quarterly dividend.Stockholders ...
Renova Pharmaceuticals launches first three US generic products
11 September 2026 - Generic medicines developer Renova Pharmaceuticals LLC announced on Thursday the commercial launch of its first three FDA-approved generic products in the United States: L-Glutamine for Oral Solution, Dimethyl Sulfoxide (DMSO) Irr...
FDA grants Priority Review to Genentech's Enspryng for MOGAD
10 September 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has granted Priority Review to its supplemental application for Enspryng (...
BioMarin announces positive Phase 3 VOXZOGO (vosoritide) study results in hypochondroplasia published in NEJM Evidence
10 September 2026 - Biotechnology company BioMarin Pharmaceutical Inc (Nasdaq:BMRN) announced on Wednesday that new data from the Phase 3 CANOPY-HCH-3 study evaluating VOXZOGO (vosoritide) in children with hypochondroplasia were published in New Engl...